EUDRATEC® SoluFlow

EUDRATEC® SoluFlow
Product Description

Evonik offers a new solubility enhancement technology and service package for small molecules used in oral drugs that are particularly challenging to dissolve. EUDRATEC® SoluFlow is the latest addition to Evonik’s platform of oral drug delivery technologies for targeted release. This process technology and service package turns poorly soluble drugs into free-flowing amorphous solid dispersions. These can then easily be compressed into tablets or filled into capsules, reducing the number and complexity of post-processing steps. The unique emulsion-based process uses standard pharma equipment to manufacture uniform microparticles that have a controlled target size and are produced at high yield. As pharmacokinetic performance is highly dependent on formulation and process, it is also possible to use this technology to improve the pharmacokinetic performance of drugs.

Evonik Industries AG

  • Country/Region:
    Germany
  • Founded:
    2007
  • On CPHI since:
    2015
  • Certificates:
    4
  • Employees:
    5000+
Company types
Manufacturer/Innovator
Specifications
  • Selling Points
    EUDRATEC® SoluFlow enables a seamless transition from pre-selection of an API to clinical formulation and then commercial manufacture. We can use this unique technology to design powders under controlled conditions with precise particle size and shape, optimize manufacturing processes for stress conditions and process steps, and scale from early preclinical development to production scale with mathematical scaling models.

Evonik Industries AG

  • Country/Region:
    Germany
  • Founded:
    2007
  • On CPHI since:
    2015
  • Certificates:
    4
  • Employees:
    5000+
Company types
Manufacturer/Innovator

More Products from Evonik Industries AG (17)

  • CDMO of Highly Potent APIs (HPAPI)

    Product CDMO of Highly Potent APIs (HPAPI)

    For more than 20 years, Evonik has been the world’s largest process developer and manufacturer of HPAPIs, with a total capacity of 170m³ and OEL down to 5 ng/m³. In addition to the development and implementation of highly potent API manufacturing processes for most classical organic reaction types, we exce...
  • Chromatocel® 150 Series

    Product Chromatocel® 150 Series

    Activated Alumina (aluminum oxide, CAS# 1344-28-1) for chromatography, batch extractions, decolorizations and more. Available in acidic, basic or neutral pHs, optimized particle size, surface area, pH, and purity make Chromatocel 150 series a particularly useful material for the separation of small molecul...
  • Chromatocel® S Series

    Product Chromatocel® S Series

    Silica gel (silicon dioxide, CAS# 112926-00-8) for chromatography, batch extractions, decolorizations and more. Optimized particle size, surface area, pH, and purity make Chromatocel S series a particularly useful material for the separation of small molecules, peptides, lipids, alkaloids, botanical extrac...
  • MaxiPure® Polysorbate 80

    Product MaxiPure® Polysorbate 80

    MaxiPure® Polysorbate 80 is a non-ionic surfactant. It is manufactured from highly pure oleic acid (≥98%), ensuring minimal impurities compared to standard grades. MaxiPure® Polysorbate 80 has reduced peroxide levels and water content, resulting in outstanding clarity.

    In injectable formulations, Po...
  • PhytoSquene®

    Product PhytoSquene®

    PhytoSquene® is the world’s first GMP-quality, plant-derived squalene. It offers a sustainable and high-quality alternative to traditional shark-derived squalene, meeting the need for sustainably sourced pharmaceutical-grade squalene. The key drivers behind its development are sustainability, safety, regul...
  • EUDRACAP® Functional ready-to-fill capsules

    Product EUDRACAP® Functional ready-to-fill capsules

    EUDRACAPTM functional ready-to-fill capsules can optimize your release profile, protect your active ingredients, and help accelerate your speed to market. EUDRACAP™ is ideal for use with active ingredients which are sensitive to heat, moisture or gastric acid to optimize absorption and avoid premature ...
  • EUDRAGIT® Portfolio of Oral Excipients

    Product EUDRAGIT® Portfolio of Oral Excipients

    Evonik is a global development partner and solutions provider for oral drug delivery. For more than 70 years, we have been providing renowned pharmaceutical and biotech companies with oral drug delivery solutions to help them enhance drug performance, reduce project complexity, increase speed to market and...
  • Noblyst® P

    Product Noblyst® P

    Noblyst® P products are precious metal powder catalysts on various support materials mostly used in batch and slurry processes. This brand also comprises a range designed for flow chemistry processes. Evonik provides a full service package, including precious metals management. With production sites in all...
  • Parenteral drug delivery solutions

    Product Parenteral drug delivery solutions

    Evonik is one of the world’s leading CDMOs for parenteral drug delivery. For complex parenteral drug products designed for systemic, targeted or localized delivery, we are uniquely positioned to serve as a global development partner and solutions provider. Our parenteral drug delivery portfolio includes th...
  • PhytoChol®: Plant-derived cholesterol

    Product PhytoChol®: Plant-derived cholesterol

    Plant-derived cholesterol for mRNA delivery, gene therapy and cell culture: Our plant-derived PhytoChol® provides you with a secure and stable supply of synthetic cholesterol. Evonik supplies PhytoChol® in two grades that are tailored to the specific needs of injectable drug delivery and biopharm...
  • Custom Lipids

    Product Custom Lipids

    Evonik has over three decades of experience formulating liposomes and lipid nanoparticles (LNPs) using variety of different lipids. Evonik also manufactures lipids, including those used in mRNA COVID-19 vaccines. We harbor a deep understanding of liposomes and LNPs, including formulation, scale up, and ...
  • Lipid nanoparticles

    Product Lipid nanoparticles

    Lipid nanoparticles (LNPs) enable the delivery of a variety of molecules, including nucleic acids such as mRNA, to cells and are therefore an essential tool in gene therapy. To unleash the potential of vaccines, protein and gene therapies, drug developers need the support of a trusted and experienced pro...

Evonik Industries AG resources (2)

  • News CPHI Pharma Award Winners 2022: Pharmaceutical Packaging & Drug Delivery – Evonik

    In this series of interviews, we speak to the teams behind the winning concepts at CPHI Pharma Awards 2022, which was held at CPHI Frankfurt, across the categories from digital innovation to CEO of the year. 

  • Industry Webinar Still Sourcing Squalene From Sharks? Phytosquene® Plant-Based Squalene for Parenteral Applications

    PhytoSquene® is the world’s first GMP-quality, plant-derived squalene. It offers a sustainable and high-quality alternative to traditional shark-derived squalene, meeting the need for sustainably sourced pharmaceutical-grade squalene. The key drivers behind its development are sustainability, safety, regulatory compliance and social responsibility. Extracting squalene from shark livers for use in parenteral pharmaceutical applications such as vaccines depletes shark populations, which impacts marine biodiversity. PhytoSquene® supports the UN Sustainable Development Goals (SDGs) of protecting ecosystems and promoting circularity, while also mitigating risks associated with bioaccumulative toxins found in animal sources, and ensuring batch-to-batch consistency and superior quality in compliance with European Pharmacopoeia standards. Made from amaranth oil and manufactured in Germany using proprietary technology, PhytoSquene® not only advances patient safety and acceptance, but also demonstrates Evonik’s commitment to next-generation solutions with a positive sustainability profile. PhytoSquene® provides vaccine manufacturers and patients peace of mind while protecting marine ecosystems.